ONPH — Oncology Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.04m
- $0.64m
- $0.01m
Annual balance sheet for Oncology Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2002 March 31st | 2003 March 31st | 2004 March 31st | 2011 June 30th | 2013 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10KSB | 10KSB | 10KSB | PRESS | ARS |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.93 | 1.35 | 0.008 | — | 0.009 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.061 | 0.171 | 0.019 | 0.015 | 0 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.1 | 1.58 | 0.048 | 0.165 | 0.187 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.503 | 0.129 | 0 | 0.062 | 0.006 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3.61 | 1.75 | 0.048 | 0.262 | 0.199 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.24 | 0.879 | 0.22 | 0.666 | 0.213 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.24 | 0.879 | 0.22 | 0.666 | 0.419 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.37 | 0.872 | -0.172 | -0.404 | -0.22 |
| Total Liabilities & Shareholders' Equity | 3.61 | 1.75 | 0.048 | 0.262 | 0.199 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |